Daily Stock List
South American Gold Corp. (SAGD)
Wallstreetlivechat, OTCPicks, and OTC Stock Review reported previously on South American Gold Corp. (SAGD), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Carbon Credits International, Inc., a leading-edge mobile technology company and full service mobile marketing agency building a family of brands, operates a best-in-class mobile commerce and communication platform. Mobile devices are rapidly changing how organizations interact with individuals, and Carbon Credits International provides state-of-the-art platforms and services that enable clients to successfully leverage the mobile evolution to their advantage.
Carbon Credits recently acquired SinglePoint, a company that works in partnership with entertainment, media companies, brand managers, advertising agencies, and mobile networks to deliver a full suite of mobile products and services. Current publisher partners include NBC Universal (Bravo, Oxygen, SyFy, CNBC, MSNBC, Telemundo, USA Network), ABC/Disney, Viacom and CBS Corp.
SinglePoint once dominated the broadcast media space for mobile messaging and were widely recognized for their high volume message routing platform that was uniquely developed for supporting the mobile industry's high volume SMS campaigns including: Deal or No Deal, Red Cross Haiti campaign, Obama '08 campaign, Beijing & Vancouver Olympics, American Idol, and many others. In addition to gaining this high volume message routing platform, Carbon Credits will has also acquired SinglePoint's SMS campaign management tool, which was used throughout broadcast media for creating and managing mobile campaigns for top brands.
Greg Lambrecht, CEO of Carbon Credits, said the following when the acquisition was announced: “With the purchase of SinglePoint's name and technologies, Carbon Credits International Inc. has instantly enhanced its ability to become a leader in the mobile messaging and mobile payments industries. This acquisition will allow us to support extremely high level text messaging programs without requiring the Company to upgrade its technology and incurring additional expense. I'm confident this will attract more business."
Carbon Credits also has their Text-a-Day and Text-4-Faith brands, which are enabling successful giving campaigns via the mobile phone for non-profit organizations. Charitable giving in the United States approaches $300 billion annually, of which more than 70% is donated by individuals, the vast majority of whom own a mobile device. A third of this market, $100 billion, is channeled to religious entities.
The Text-4-Faith platform provides targeted services allowing ministries to engage members with enhanced communication and enabling their ability to donate via their mobile phone. Similarly Text-a-Day provides these capabilities for any nonprofit organization focused on engaging supporters and driving fundraising. Text-a-Day also enables nonprofits to effectively engage consumers with targeted marketing campaigns that drive transactions through its mobile commerce platform.
South American Gold Corp. (SAGD), closed Friday's trading session at $0.0019, up 35.71%, on 24,881,128 volume with 124 trades. The average volume for the last 60 days is 4,304,996 and the stock's 52-week low/high is $0.001/$0.10.
Scout Exploration, Inc. (SCXN)
The Green Baron reported this week on Scout Exploration, Inc. (SCXN), ThePUMPTracker did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Scout Exploration, Inc. focuses on the development of innovative solutions to the challenges of offshore, shoreline, and inland spill incidents for the oil and gas exploration, production, as well as transportation sectors. The Company is concentrating on the IDS Oil-Spill Response System. They indicate that this system provides a new and essential tool for oil spill response of the future. The Company incorporated on February 1, 1999. Scout Exploration shares trade on the OTC Markets' OTCQB.
Since 2008, the IDS Oil-Spill Response System has been under development by IDS Offshore, Inc. at the Canadian NRC Institute for Ocean Technology, St John's, Newfoundland. The system takes advantage of existing infrastructure and training, and provides major advantages in oil spill remediation because the Unmanned Spill Response Vessels (USRVs) are engineered for deployment from the air. The IDS Oil-Spill Response System lessens critical time to first-response.
The IDS Oil Spill Response system, based at strategic locations, forms a coastal safety net to provide a national or continental network of first response oil spill containment technology. The system, utilizing existing naval and/or coast guard facilities, along with commercial locations, offers wide area mitigation to reduce ecological damage and the economic costs of oil spill incidents substantially. The Scout airborne system deploys to reach remote offshore spills hours or days before current ship-borne methods.
This week, Scout Exploration reported that a recent ban in offshore drilling licenses in Arctic waters could mean new opportunity for the Company. Their air-deployed spill response system is capable of reaching distant offshore spills faster than current methods.
The Company indicates that it could be a part of a balanced approach toward responsible offshore development, operation and advancing environmental protection. Scout Exploration has been working in cooperation with industry and government to advance their unmanned, remote, air-deployed spill response system to advance the project through prototype to initial sea trials. Growth in offshore drilling between Quarter 1 2011 and Quarter 4 2012 represents an expanding market for the Scout IDS Airborne Spill Response System.
Scout Exploration, Inc. (SCXN), closed Friday's trading session at $0.28, even for the day, on 331,296 volume with 44 trades. The average volume for the last 60 days is 21,799 and the stock's 52-week low/high is $0.0495/$0.41.
The SpendSmart Payments Company (SSPCD)
We are reporting on The SpendSmart Payments Company (SSPCD) today, here at the QualityStocks Daily Newsletter.
The SpendSmart Payments Company is a provider of payment solutions that support smart spending habits. The Company's primary product is the SpendSmart prepaid card for teens. This card offers resources to families with teenagers who want to learn responsible spending habits. The Company formerly went by the name BillMyParents, Inc. They changed their name to The SpendSmart Payments Company in February of this year. The Company is based in San Diego, California.
The SpendSmart card provides users with contemporary methods of developing financial literacy, centered on a card solution for parents whose goal is to guide their teens in making sensible, economic choices. The card helps open the lines of communication between parent and teen through tracking spending in real time. The card creates teachable moments around smart spending habits.
The SpendSmart card can be used at ATM locations. No credit history is required to obtain a SpendSmart Card because it is a prepaid or pre-funded card. Monthly Fees and Inactivity Fees are typically charged to the Parent's primary funding source (provided at the time of card order and initial funding). The SpendSmart Card is available for parents that are legal U.S. residents, 18 years and older who have a Social Security Number and a U.S. mailing address. When requested by a parent, the card is issued to teenagers over the age of 13.
Earlier this month, The SpendSmart Payments Company announced, that along with international pop/R&B music phenomenon and SpendSmart brand ambassador, Justin Bieber, they will launch a series called "REAL TALK" supporting the SpendSmart prepaid card. The card's goal is to educate families and teenagers about responsible spending habits, while allowing parents to monitor teen spending online by way of real-time text alerts, and providing them with access to financial education tools and resources.
"REAL TALK" is a series of videos supporting the Company's teen product, the SpendSmart prepaid card. The series will feature Justin Bieber speaking the truth about the lessons he learned about responsible spending. Through texts, emails, and videos, Justin Bieber will personally share what teens need to hear concerning finances, while encouraging families to start the conversation about financial responsibility.
The SpendSmart Payments Company (SSPCD), closed Friday's trading session at $5.40, down 10.00%, on 5,544 volume with 26 trades. The average volume for the last 60 days is 2,618 and the stock's 52-week low/high is $3.1484/$13.50.
Gold Dynamics Corp. (GLDN)
OtcWizard and Center Stage Stocks reported earlier on Gold Dynamics Corp. (GLDN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Gold Dynamics Corp. is an emerging precious metals explorer. The Company's primary operations began in 2006 and they are concentrating on underexplored regions of the world. Gold Dynamics is working on building gold and silver mineral resources by way of systematic exploration. They look to identify, acquire, and develop deposits that have the potential to be world class and in an acceptable risk environment. Gold Dynamics has their headquarters in Henderson, Nevada.
Gold Dynamics acquired in March 2012,, by option, the Hoyle North property in the prolific Timmins gold mining camp in Ontario, Canada. The property consists of 32 claim units that represent approximately 12 square kilometers. The property is near the west end of the Neo- Archean Abitibi greenstone belt, approximately 18 km northeast of Timmins and 6 kilometers north of the Porcupine-Destor fault.
The Company will acquire 100 percent of the property for cash payments over three years amounting to $95,000.00 and work expenditures totaling $110,000.00 with a 2 percent Net Smelter Return (NSR) granted to the vendors.
Gold Dynamics reported in December 2012 that they contracted with Geotech Ltd. to complete a helicopter borne Versatile Time Domain Electromagnetic (VTEM Plus) and Horizontal Magnetic Gradiometer Geophysical Survey on the Hoyle North Palladium-Platinum-Gold Project in Timmins, Ontario. They acquired 84 line kilometers of geophysical data, flown at 100 meter spacing on the property.
Analysis of the preliminary data from the VTEM Plus indicates mineralized targets exist in the eastern portions and a mineralized trend from the southeast to the northwest of the property at approximate depths of 200 meters. The survey also identifies a system of dykes that are very common in mineralized zones on this trend and are common to the known geology of this locale.
More results and analysis will undergo evaluation to choose targets for ground follow-up to help prioritize anomalies for drilling. The Hoyle North property is contiguous to Goldcorp's Hoyle Pond mine. Furthermore, it is within short distances to major resources including Owl Creek and Bell Creek.
Gold Dynamics Corp. (GLDN), closed Friday's trading session at $0.01, even for the day, on 63,150 volume with 3 trades. The average volume for the last 60 days is 82,976 and the stock's 52-week low/high is $0.001/$0.0138.
Difference Capital Funding, Inc. (DCF.V)
Today we are reporting on Difference Capital Funding, Inc. (DCF.V), here at the QualityStocks Daily Newsletter.
Difference Capital Funding, Inc. is a merchant bank whose shares trade on the TSX Venture Exchange. The Bank focuses on strategic investments in, and advisory services for, growth companies, more specifically in the technology, media and healthcare sectors. They additionally focus on opportunistic investments in undervalued financial assets and real property. Difference Capital Funding has their corporate headquarters in Toronto, Ontario.
The Company established to capitalize on the areas of technology, media, as well as Intellectual-Property (IP) rich industrial companies. Difference Capital Management, Inc. has managed Difference Capital Funding since May 2012. Difference Capital offers advisory and consulting services to assist their clients. In essence, the Company concentrates on non-resource, mid-market opportunities.
The Company's investments include Virgin Gaming. Virgin Gaming is the world's largest destination for competitive console gamers to meet, challenge and play in tournament challenges for cash, points, as well as prizes.
Difference Capital is investing globally in companies that are IP rich that have clear competitive advantages in large and growing markets; and that have proven business models with visibility to $10 million+ of revenue and positive EBITDA. They invest in companies with solid credible customer traction. Difference Capital takes an active role in the major positions they have and receive fees from their broad based advice.
Last week, Difference Capital Funding announced their financial results for the year ended December 31, 2012. Highlights for 2012 and financial results include the Company changing their name to Difference Capital Funding, Inc. and a change in business focus. On May 24, 2012, Difference Capital Funding established as a merchant bank, with a new management team and changed strategic plan. Before this date, they operated as TriNorth Capital, Inc., an investment company with a focus on the agricultural sector.
Concerning financial highlights, Difference Capital Funding raised $85 million in equity capital, had Revenue of $7.8 million and Net Income of $4.3 million. In addition, they had Shareholders' Equity of $90 million at December 31, 2012.
Difference Capital Funding, Inc. (DCF.V), closed Friday's trading session at $0.445, down 1.11%, on 1,416,000 volume. The stock's 52-week low/high is $0.04/$0.50.
DynaVox, Inc. (DVOX)
Street Insider reported previously on DynaVox, Inc. (DVOX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
DynaVox, Inc. is the foremost provider of speech generating devices and symbol-adapted special education software used to assist individuals in overcoming their speech, language and learning challenges. The Company's principal operating entities are DynaVox Systems, LLC and Mayer-Johnson LLC. DynaVox offers their speech generating devices to speech language pathologists. They offer special education software to special education teachers and speech language pathologists.
DynaVox completed an initial public offering (IPO) on April 27, 2010. Because of the IPO and certain other recapitalization transactions, the Company became the sole managing member of and has a controlling interest in DynaVox Systems Holdings, LLC and their subsidiaries (DynaVox Holdings). DynaVox has their corporate headquarters in Pittsburgh, Pennsylvania.
DynaVox assists individuals, families, and professionals with a broad field support organization and centralized technical and reimbursement support. DynaVox sells their speech generating devices by way of a direct sales force and via strategic partnerships with third-party distributors around the world. The Company sells their special education software through direct mail, direct sales, as well as through the Internet.
The Company's corporate mission is to enable their customers to realize their full communication and education potential through developing industry-leading devices, software and content and by providing the services to support them. The design of their solutions is to assist people who have complex communication and learning needs in participating in the home, classroom and community.
DynaVox's speech generating technology solutions include DynaVox Maestro, a tablet product line of speech generating devices. Their solutions additionally include DynaVox Vmax+, a Series V product line designed to meet individual needs based on cognition and physical ability to operate the device. Moreover, DynaVox's solutions include the EyeMax system consisting of Vmax and an EyeMax accessory, which allows users to control the Vmax with an easy blink or by causing the eye to dwell on a desired area of the screen. These are among other products that the Company offers.
The use of the Company's Boardmaker line of special education software is as a publishing and editing tool to create interactive, symbol-based educational activities and materials for special education students. In addition, it is utilized to adapt text-based materials to symbol-based materials for students with limited reading skills. DynaVox's proprietary Picture Communication Symbols (PCS®) are used in their Boardmaker software line and their DynaVox line of speech generating devices.
DynaVox, Inc. (DVOX), closed Friday's trading session at $0.211, up 24.12%, on 275,504 volume with 53 trades. The average volume for the last 60 days is 52,380 and the stock's 52-week low/high is $0.126/$0.288.
Medizone International, Inc. (MZEI)
SmarTrend Newsletters reported recently on Medizone International, Inc. (MZEI), SmallCapVoice did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Medizone International, Inc. and their subsidiaries has been a development stage company conducting research into the use of ozone in the disinfection of surgical and other medical treatment facilities and in other applications. During 2012, the Company emerged from the development stage; they started to sell their patented ozone disinfection system, AsepticSure. Medizone International lists on the OTC Markets' OTCQB. The Company has their corporate headquarters in Sausalito, California.
Medizone took delivery at the end of January 2013 of the first AsepticSure system constructed by their new contract manufacturer, Transformix Engineering. Transformix delivered an additional three units from the initial build order during February 2013. The units passed performance confirmation testing at Medizone's Innovation Park laboratories.
Subsequent to December 31, 2012, Singapore issued Medizone International their Health Care Patent. The Company considers this significant for their business growth in Asia. Medizone believes Singapore could become a lucrative market for AsepticSure sales; the medical system in Singapore looks to distinguish itself with the safest hospitals possible to promote continued growth in the expanding medical tourism market.
Medizone International completed successful safety and preliminary operational trials of the AsepticSure system at the Belleville General Hospital site of Quinte Health Care in Canada, in January of this year. In collaboration with Contamination Control Company (C3), an Ontario-based provider of AsepticSure services in Canada, the belief is that these trials are to demonstrate clearly the safety and ease of operation of the AsepticSure disinfection system in a functioning health care setting. The turnaround time for disinfection and reoccupation of the hospital rooms was less than 90 minutes during the tests.
This month, Medizone International and Wood Wyant Canada jointly announced that Wood Wyant has become a National Hospital Distributor of AsepticSure in Canada. Wood Wyant is a subsidiary of Sanimarc Group. They serve Canada from 16 different locations across all 10 provinces. They provide sales and service to the hospital market.
Medizone International, Inc. (MZEI), closed Friday's trading session at $0.147, up 50.00%, on 3,913,843 volume with 524 trades. The average volume for the last 60 days is 151,326 and the stock's 52-week low/high is $0.06/$0.22.
American Graphite Technologies, Inc. (AGIN)
Greenbackers, TooNiceStocks, PennyStocks24, Stock Brain, HEROSTOCKS, Liquid Pennies, VIP STOCK ALERTS, Stockhunter.us, Wyatt Investment Research, and Trade of the Week reported this month on American Graphite Technologies, Inc. (AGIN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Based in Las Vegas, Nevada, American Graphite Technologies, Inc. is a mineral exploration and technology development company. They are focusing on securing graphite mining opportunities and the commercialization of graphene specific proprietary technology methods. The Company previously went by the name Green & Quality Home Life, Inc. They changed their corporate name to American Graphite Technologies, Inc. in July 2012. The Company's shares trade on the OTC Markets' OTCQB.
Graphene is believed to be stronger than steel and more conductive than copper, while being flexible. This makes it viable as a replacement over silicon possibly leading to thinner, faster, cheaper, more flexible devices including power sources. Graphene comes from the carbon atom; for that reason, it is abundant and inexpensive.
American Graphite Technologies has their Lac Nicolas Graphite Property. They have 100 percent ownership of 100 mineral claims covering approximately 5,400 hectares (13,343 acres) of land in the Province of Quebec. No Royalty or Net Smelter Return (NSR) is attached to this property. The property is in an underexplored relatively new graphite exploration area with significant upside potential for new discoveries.
The Lac Nicolas Graphite Property, geologically, is underlain by rocks of Granville Province and Archean basement and is similar to other graphite deposit/discoveries in the area. The Property is part of the area designated as "Plan Nord" for major economic, social and environmental development as announced by the Quebec Government.
In March, American Graphite Technologies announced the successful production of test samples of a Graphene Paper product by their development and manufacturing partner CTI Nanotechnologies, LLC. Graphene Paper has the potential to transform the automotive, aviation, electrical and optical industries. Currently, Graphene Paper is available only in limited sizes, is relatively expensive, and is especially time consuming to make.
This week, American Graphite Technologies announced that they completed a Letter of Intent (LOI) with the National Academy of Science of Ukraine; National Science Centre; Kharkiv Institute of Physics and Technology (KIPT), Kharkov, Ukraine. The scope of the collaboration will be to research the properties of graphene contained matter as working material for 3-D printing.
American Graphite Technologies, Inc. (AGIN), closed Friday's trading session at $0.79, down 4.49%, on 849,713 volume with 477 trades. The average volume for the last 60 days is 466,444 and the stock's 52-week low/high is $0.40/$2.00.
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.498, up 55.14%, on 48,261 volume with 22 trades. The stock’s average daily volume over the past 60 days is 61,277, and its 52-week low/high is $0.25/$1.25.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Brings Luxuria Brands to the Silver Screen
ASCC Leadership Travels to Las Vegas to Discuss Launch Opportunities for New Vodka
ASCC Looks to Apple, Social Media to Promote New Brands
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.88, up 25.71%, on 2,200 volume with 2 trades. The stock’s average daily volume over the past 60 days is 3,417, and its 52-week low/high is $0.06/$2.60.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Announces $36 Million Strategic Financing Agreement
VistaGen Therapeutics to Present Enhancements and Expanded Validation of LiverSafe 3D™ at Society of Toxicology's 52nd Annual Meeting
VistaGen Therapeutics to Present CardioSafe 3D(TM) Developments at Society of Toxicology's 52nd Annual Meeting
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.0725, up 10.52%, on 302,487 volume with 177 trades. The stock’s average daily volume over the past 60 days is 371,908, and its 52-week low/high is $0.0618/$0.28.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium Receives ISO Certification for Excellagen
Cardium's To Go Brands® to Launch Expanded VitaRocks® kids Vitamin Line With New Retail Distribution
Cardium's Excellagen® Awarded American Podiatric Medical Association Seal of Approval, Company Also Announces Addition of a Regional Distributor for Excellagen
Rafarma Pharmaceuticals, Inc. (RAFA)
The QualityStocks Daily Newsletter would like to spotlight Rafarma Pharmaceuticals, Inc. (RAFA). Today, Rafarma Pharmaceuticals, Inc. closed trading at $0.15, up 7.14%, on 20,800 volume with 4 trades. The stock’s average daily volume over the past 60 days is 13,343, and its 52-week low/high is $0.0501/$0.98.
Rafarma Pharmaceuticals, Inc. (RAFA) is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia.
Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by the Ministry of Health.
Rafarma recently received the general license for pharmaceutical products and began manufacturing three new products: Sodium Para-Aminosalicilate, Ibuprofen, and Betagistin. Receiving the general license was one of the final steps the company needed to open its new plant in Terbuniv, and Rafarma has been named one of only four national strategic pharmaceutical suppliers to the Russian Federation.
Advances in health care science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. Elderly citizens, which comprise the largest portion of the pharmaceuticals market, have bolstered demand for pharmaceuticals nationwide. Rafarma is well positioned to capitalize on the expanding industry with its strong relationships and state-of-the-art production facility. Disclaimer
Rafarma Pharmaceuticals, Inc. Company Blog
Rafarma Pharmaceuticals, Inc. News:
Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
Rafarma Pharmaceuticals Registers CEFTRIAXONE Under International Label
Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
Green Technology Solutions, the aggressive young company which has made a name for itself by attacking the resource equation from both the mining and recycling sides, hunting for rare earths and precious minerals with the drill and via the landfill, reported progress today in their continued negotiations (aimed at striking a definitive agreement) with Chilean recycler, Chilerecicla, who is putting together a network of e-waste suppliers in Latin America.
This network would pump out valuable minerals for direct sale to overseas smelting markets and represents a huge win for Chilerecicla, who will be able to lock in favorable prices from e-waste suppliers, resulting in a healthy profit margin. Urban mining as it’s called will become an increasingly important part of the overall resource sector moving forward, as a rising percentage of total inputs are derived from recycled sources. This fact is the primary reason GTSO is positioning itself now for a leadership role in this burgeoning industry.
CEO of GTSO, Paul Watson, praised the business model Chilerecicla has developed and asserted to investors that the company was dead set on striking a partnership deal ahead of Chilerecicla breaking out as a major new player on the urban mining scene. Watson projected clear signals that GTSO is working very hard to secure an agreement whereby the company will help Chilerecicla expand operationally and in exchange receive both the vital industry contacts and best practices know-how required to emulate their model state side.
The goal will be to apply gleaned expertise from the Chilerecicla relationship as time progresses, honing in on the best ways to isolate e-waste before it ever gets to a landfill. This capacity, in combination with prevailing domestic legislative measures, will place GTSO in the pole position for turning landfill-bound e-trash into cold hard cash, as well as bottom line growth for their shareholders.
GTSO is intent on growing into a firm that can compete alongside major sector players like Industrial Services of America (IDSA) and Sims Metal Management (SMS), looking to springboard off the acquisition of Global Cell Buyers late last year, which was quickly re-branded by GTSO as Green Urban Mining in order to enhance focus of recycling/resale operations. This deal with Chilerecicla would be a big step towards realization of the company’s domestic urban mining strategy, stripping highly valuable elements such as gold, lithium, neodymium, and palladium from discarded electronics, helping to save the environment while tapping into a blossoming growth industry.
For more info on Green Technology Solutions, check out www.GTSOresources.com
Oncology-focused company Curis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended conditional approval of Erivedge (vismodegib) for treating adult patients with symptomatic metastatic basal cell carcinoma, or locally advanced basal cell carcinoma that is not appropriate for surgery or radiotherapy. Receiving conditional approval would make Erivedge Europe’s first licensed treatment for patients with advanced basal cell carcinoma, which is a rare form of skin cancer that can be disfiguring, debilitating, and even fatal.
“We are extremely pleased that the CHMP has recommended the conditional approval of Erivedge in the EU and we hope that this important medicine will soon be available to patients in Europe,” said Curis CEO Dan Passeri. “We continue to be pleased by the strength of Roche’s global regulatory and commercialization efforts regarding Erivedge, which we anticipate will significantly broaden patient access to Erivedge globally. Erivedge is currently under review for approval by health authorities in several countries outside of Europe, and regulatory submissions are planned in many additional countries. We view Roche’s broad efforts to expand patient access to Erivedge as a testament to its commitment to this important, first-in-class molecule.”
Possessing the authority to approve medicines for use in the European Union, the European Commission generally delivers final decisions within three months of the CHMP recommendation. The final decision will apply to all 27 member states of the EU. A conditional approval from the European Commission would mean a $6 million milestone payment for Curis from Genentech, which is a member of the Roche Group. The Roche Group is responsible for the commercialization of Erivedge in the EU.
Based on quality, safety, and submitted efficacy data, the CHMP stated it considers there to be a favorable benefit-to-risk balance for Erivedge and, therefore, recommended the granting of marketing authorization, which is conditional and will require submission of additional data from ongoing studies. The CHMP grants conditional approval for medicinal products that fulfill an unmet medical need.
For more information, visit www.curis.com
Velti, the premier provider of mobile marketing and advertising technology worldwide, and Bauer Media Group UK, owner of many of the most successful and influential radio in the United Kingdom, announced today that have entered into a two-year, exclusive mobile marketing partnership. The agreement between the two companies stipulates that the mobile interactivity, marketing, and promotions for Bauer’s 43 radio stations will be managed and maintained by Velti. This includes all mobile messaging for brands such as Magic 105.4, KISS, Clyde 1, Key103, Radio City, Wave105 and Kerrang.
This promising endeavor will support Bauer Media’s ongoing initiative to develop and grow its relationship with its audiences. Velti will focus on compliance and operational excellence while coordinating all of Bauer’s mobile messaging and interactivity. In addition, Velti will incur the development of new concepts designed to increase audience engagement and loyalty using data and customer relationship management (CRM) mechanics.
“Our aim is to develop closer relationships with our audience by providing mobile engagement opportunities and interactivity throughout our campaigns,” said Joanne Baldwin, Digital Commercial Director at Bauer Radio. “Our listeners expect the best from Bauer so we wanted to work with the best supplier in the market. Velti is a partner we can trust and rely upon to deliver these mobile marketing services while also guiding and advising us on how to best capitalize on technology advancements in the mobile and digital landscape.”
Rob Weisz, Vice President of Sales at Velti, said, “Velti has worked closely with Bauer to ensure a seamless implementation across the entire portfolio of mobile interactive services. After launching the existing interactive services, we are working with Bauer to optimise and develop elegant CRM and marketing mechanics using data generated from SMS interactivity, as well as our range of platforms and technologies. Bauer has great ambitions and is driven to push new and exciting initiatives. We look forward to helping Bauer and its portfolio of brands capitalise on emerging trends that can drive real consumer value.”
For further information, visit www.velti.com
Terra Tech Corp., a leader in sustainable agricultural products, is pleased to announce it has completed its acquisition of Edible Garden and its line of locally grown hydroponic produce, which is distributed throughout the northeast.
Edible Garden a premier local brand of sustainably grown produce has rapidly expanded its product availability from just over 100 retail stores to covering close to 400 retailers throughout New Jersey, Connecticut, Delaware, Maryland, New York and Pennsylvania in less than a year. This rapid expansion has been due to consumers demanding fresher produce grown locally using environmentally sustainable methods.
“Edible Garden is fast becoming one of the leading brands in their market,” said Derek Peterson CEO of Terra Tech. “We feel we have an opportunity to replicate the success they created in the northeast throughout the rest of the country. We are in active discussions with other urban farmers throughout the US to cultivate sustainably under Edible Gardens’ standards. We are in the beginning stages of creating a national brand comprised of local farmers. We are looking forward to showing our fiscal growth to shareholders beginning in Q2.”
The cost of acquisition was 1,250,000 shares of common stock. One of Terra Tech’s directors Amy Almsteier will be surrendering 500,000 shares of common stock back to the company to help offset the acquisition cost. During due diligence Terra Tech discovered some change of ownership covenants that existed within GroRites and NB Plants credit facilities that required the companies to refinance. The cost associated with refinancing proved too significant for the company and shareholders to absorb at the present time. Management made the decision to absorb Edible Garden, the biggest growth company, from the Vande Vrede’s while structuring the acquisition to benefit from the current revenue base of both GroRite as well as NB Plants through distribution contracts, which Terra Tech is currently being negotiated.
“The new structure is far less dilutive to shareholders yet we have the benefit of the current business as well as the upside of our regional and national expansion,” said Ken Vande Vrede COO of Terra Tech. “As far as we know Terra Tech is the only public company focused on urban agriculture, and we feel with a ballooning population as well as shrinking arable land, urban Ag is going to be a necessity to feed our populations.”
The company has recently begun its regional expansion plan by purchasing and planning the construction of an additional 5 acres of greenhouse on the Belvidere property. This facility will be solely dedicated to producing the full line of Edible Garden products for sale throughout their local market. At full capacity and at current prices this facility can produce close to $10 million in sales annually for Terra Tech. The company anticipates having this facility completed by year end.
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) and FusionVax Sign a Memorandum of Understanding for the License of Advaxis’ ADXS-HPV in Asia
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- DoMark International, Inc. (DOMK) Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Fourth Quarter 2012 Financial Results and Provides Business Update
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Low Carbon Technologies International, Inc. (LWCTF) Poised for Up-Listing; Looks Toward OTCQX Market on Heels of Upcoming Quarterly Financial Disclosure
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Looks Overseas for Potentially Lucrative Licensing Opportunities
- The Aristocrat Group Corp. (ASCC) Brings Luxuria Brands to the Silver Screen
- The Guitammer Company Inc. (GTMM) Issues Shareholder Letter Recapping 2012 and Outlining 2013 Focus
- VentriPoint Diagnostics Ltd. (VPTDF) Receives Request for Clarification to 510 (k) Submission for Pulmonary Arterial Hypertension
- Viaspace, Inc. (VSPC) 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement